LXRX (Lexicon Pharmaceuticals) Future Price to Earnings

Corporate emblem and logo of Lexicon Pharma (LXRX)

This price trend chart for Lexicon Pharmaceuticals (LXRX), which stands at 0.00, demonstrates the impact of the company's strategy to create comprehensive solutions for kidney and heart therapy. Growth is supported by the hiring of a commercial team to promote drugs, although staffing stability is tied to the market success of the products. The business is based on the development of medications to combat metabolic disorders and diabetes.

LXRX - Lexicon Pharmaceuticals Inc Projected Price to Earnings Ratio over the range 07/04/2022 - 11/15/2026

Analytical breakdowns for Lexicon Pharmaceuticals

- current price and projected stock value:
General company analysis:LXRX lexpharma.com
Brand item of Lexicon Corp

For Lexicon Pharmaceuticals (LXRX), the forward P/E chart reflects market expectations amid fierce competition with pharma behemoths. This ratio compares the current share price with the projected earnings per share. The indicator's trend captures whether the market is pricing in revenue growth or a fundamental business decline. For Lexicon Pharmaceuticals (LXRX), this is a critical marker of marketing effectiveness for new drugs against blockbusters. This analysis allows investors to distinguish between an undervalued asset and the risk of a value trap.

Competitors of Lexicon Pharmaceuticals (LXRX)

Projected Price to Earnings ASND (Ascendis Pharma Inc.)|MDGL (Madrigal Corp) - Future Price to Earnings Multiple|Future Price to Earnings corcept.com CORT|RYTM - Projected Price to Earnings|Akero Corp - Forward P/E Multiple|Projected Price to Earnings Ratio Metsera Corp|MLTX (MoonLake) - Projected Price to Earnings|CRNX: Market Cap to Future Earnings Ratio|NAMS (NewAmsterdam Pharma Corp) - Forward P/E Multiple|Forward P/E Multiple Soleno Therapeutics|Forward P/E Multiple FOLD|Future Price to Earnings ETNB (89bio Inc)|Future Price to Earnings agios.com AGIO|Structure Corp (GPCR) - Projected Price to Earnings Ratio|MDXG - Future Price to Earnings|RZLT: Future Price to Earnings|MBX Biosciences, Inc. (MBX) - Future Price to Earnings|ALT - Market Cap to Projected Earnings|Future Price to Earnings Aardvark Pharma|Sagimet Biosciences Inc (SGMT) - Market Cap to Projected Earnings|Future Price to Earnings bioagelabs.com (BIOA)|Projected Price to Earnings Biomea Fusion, Inc. BMEA|Future Price to Earnings Quince QNCX|GUTS (Fractyl Health Inc.) - Price to Expected Earnings Ratio|VTVT: Projected Price to Earnings|Forward Price to Earnings Multiple agapeatpgroup.com (ATPC)|PLUR (Pluri) - Projected Price to Earnings|Price to Future Earnings Ratio SYBX|Future Price to Earnings Lipocine Corporation|matinasbiopharma.com (MTNB) - Market Cap to Projected Earnings|Forward P/E Multiple SPRB|Projected Price to Earnings Galecto, Inc. GLTO|Future Price to Earnings Carmell Corporation CTCX|Future Price to Earnings Multiple LUMO|ONVO: Projected Price to Earnings|Future Price to Earnings Multiple RDUS (Radius Recycling Inc.)